ArticleFrontiers in oncology2019

First Line Androgen Deprivation Therapy vs. Chemotherapy for Patients With Androgen Receptor Positive Recurrent or Metastatic Salivary Gland Carcinoma-A Retrospective Study.

Paul V Viscuse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.